Similar articles

• Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis.

  Tay SH, Lateef A, Cheung PP. Tay SH, et al. Int J Rheum Dis. 2012 Aug;15(4):e71-2. doi: 10.1111/j.1756-185X.2012.01705.x. Epub 2012 Feb 13. Int J Rheum Dis. 2012. PMID: 22898230 No abstract available.
• Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature.

  Alloway JA, Mitchell SR. Alloway JA, et al. J Rheumatol. 1993 Feb;20(2):409-11. J Rheumatol. 1993. PMID: 8097252 Review. No abstract available.
• Acute myocardial infarction in a 56-year-old female patient treated with sulfasalazine.

  Daoulah A, Alqahtani AA, Ocheltree SR, Alhabib A, Ocheltree AR. Daoulah A, et al. Am J Emerg Med. 2012 May;30(4):638.e1-3. doi: 10.1016/j.ajem.2011.02.018. Epub 2011 Apr 22. Am J Emerg Med. 2012. PMID: 21514761
• Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?

  Savastano M, Marioni G, Bernini G, Punzi L. Savastano M, et al. Acta Otolaryngol. 2005 Jun;125(6):671-3. doi: 10.1080/00016480510026962. Acta Otolaryngol. 2005. PMID: 16076720 Review.
• Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis.

  Paul RH, Toder JS, Cohen RA. Paul RH, et al. Arthritis Care Res. 1999 Dec;12(6):435-6. doi: 10.1002/1529-0131(199912)12:6<435::aid-art12>3.0.co;2-4. Arthritis Care Res. 1999. PMID: 11081015 No abstract available.